Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001144204-14-003318

Chief Executive Officer acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Carpenter George C IV Chief Executive Officer 2014-01-21 Grant or award +200,000 $0.25 $50,000 1,340,799 D: show line 1 in the form
Loading xslF345X03/v365902_form4.xml…